The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
Another MR study found that genetically-predicted lowering of LDL-C is associated with decreased frailty in midlife and older age. The study also found that larger effects were observed when excluding younger participants <60 years old.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Another MR study found that genetically-predicted lowering of LDL-C is associated with decreased frailty in midlife and older age. The study also found that larger effects were observed when excluding younger participants <60 years old.
Another study linked genetically lowered LDL-C with reduced frailty in older adults, especially those over 60.
Another MR study found that genetically-predicted lowering of LDL-C is associated with decreased frailty in midlife and older age. The study also found that larger effects were observed when excluding younger participants <60 years old.